[1]
“CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY”, Mediterr J Hematol Infect Dis, vol. 2, no. 2, p. e2010020, Aug. 2010, doi: 10.4084/mjhid.2010.020.